☆ 4.0 Article

In vitro activity of exebacase against methicillin-resistant Staphylococcus aureus biofilms on orthopedic Kirschner wires

BMC RESEARCH NOTES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Microbiology

Activity of Exebacase (CF-301) against Biofilms Formed by Staphylococcus epidermidis Strains Isolated from Prosthetic Joint Infections

Aubin Souche et al.

Summary: This study evaluated the activity of the lysin exebacase against Staphylococcus epidermidis biofilms. It found that exebacase significantly reduced the biomass and bacterial count of S. epidermidis biofilms, and exhibited synergistic effects with rifampicin, vancomycin, or daptomycin. These findings suggest that exebacase could be a promising therapy for prosthetic joint infections.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

添加到收藏夹

Article Infectious Diseases

Locally delivered antistaphylococcal lysin exebacase or CF-296 is active inmethicillin-resistant Staphylococcus aureus implant-associated osteomyelitis

Melissa Karau et al.

Summary: The study demonstrates that local delivery of exebacase or CF-296 can be an effective complement to conventional antibiotics for the treatment of implant-associated infections.

JOURNAL OF BONE AND JOINT INFECTION (2022)

添加到收藏夹

Article Microbiology

Exebacase in Addition to Daptomycin against MRSA

Razieh Kebriaei et al.

Summary: Exebacase is a lysin that shows lytic activity against Staphylococcus aureus, including MRSA. Time-kill analysis experiments demonstrate the bactericidal activity of exebacase-daptomycin combination against MRSA strains. Additionally, in an ex vivo pharmacokinetic/pharmacodynamic simulated model, exebacase in combination with daptomycin reduces CFU/g counts of MRSA strain MW2 effectively.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Microbiology

Exebacase Is Active In Vitro in Pulmonary Surfactant and Is Efficacious Alone and Synergistic with Daptomycin in a Mouse Model of Lethal Staphylococcus aureus Lung Infection

Steven M. Swift et al.

Summary: Exebacase, a novel antistaphylococcal lysin in phase 3 of clinical development, has shown activity against both methicillin-sensitive and methicillin-resistant Staphylococcus aureus. It has the potential to synergize with antistaphylococcal antibiotics, demonstrating promise as a treatment for staphylococcal pneumonia.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Microbiology

Exebacase Demonstrates In Vitro Synergy with a Broad Range of Antibiotics against both Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus

Aubrey Watson et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Article Microbiology

Effect of the Lysin Exebacase on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis as Determined by Echocardiography

Sonia U. Shah et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis

Vance G. Fowler et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Article Microbiology

Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureus

Jun Taek Oh et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Article Microbiology

Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis

Aubrey Watson et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Article Microbiology

Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats

Melissa J. Karau et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Article Infectious Diseases

In vitro activity of Exebacase (CF-301) against clinical Staphylococcus aureus surveillance isolates from the United States, Europe, and Latin America, 2015-2017

Maria Traczewski et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)

添加到收藏夹

Review Endocrinology & Metabolism

Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis

Gowrishankar Muthukrishnan et al.

CURRENT OSTEOPOROSIS REPORTS (2019)

添加到收藏夹

Review Cell & Tissue Engineering

Evolving concepts in bone infection: redefining biofilm, acute vs. chronic osteomyelitis, the immune proteome and local antibiotic therapy

Elysia A. Masters et al.

BONE RESEARCH (2019)

添加到收藏夹

Article Microbiology

Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent

Raymond Schuch et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

Article Immunology

Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus-Induced Murine Bacteremia

Raymond Schuch et al.

JOURNAL OF INFECTIOUS DISEASES (2014)

添加到收藏夹

Article Immunology

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America

Douglas R. Osmon et al.

CLINICAL INFECTIOUS DISEASES (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.